Dual-Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy.
Zhang Y, Ma H, Li L, Sun C, Yu C, Wang L, Xu D, Song X, Yu R.
Adv Mater. 2024 Jul;36(29):e2400502. doi: 10.1002/adma.202400502. Epub 2024 May 13.
PMID:38651254
Crossing the blood-brain barrier: emerging therapeutic strategies for neurological disease.
Pedder JH, Sonabend AM, Cearns MD, Michael BD, Zakaria R, Heimberger AB, Jenkinson MD, Dickens D.
Lancet Neurol. 2025 Mar;24(3):246-260. doi: 10.1016/S1474-4422(24)00476-9. Epub 2025 Jan 22.
PMID:39862873
Inter-Laboratory Validation of Nodal/Paranodal Antibody Testing.
Lleixà C, Titulaer M, Rohrbacher S, Mgbachi V, Halstead S, Fehmi J, Pascual-Goñi E, Zhu L, Appeltshauser L, Franken S, Paunovic M, Waters P, Willison H, Sommer C, Querol L, Huizinga R, Doppler K, Rinaldi S.
J Peripher Nerv Syst. 2025 Mar;30(1):e70000. doi: 10.1111/jns.70000.
PMID:39887819
Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats.